Search This Blog

Monday, December 19, 2022

Abbott Launches Smallest Implantable, Rechargeable Spinal Cord Stimulation System

 

  • The U.S. Food and Drug Administration (FDA) approved Abbott's Eterna™ spinal cord stimulation (SCS) system for the treatment of chronic pain

  • This neuromodulation device provides an optimized experience with the ability to wirelessly charge as few as five times per year, the lowest recharge burden compared to other rechargeable SCS systems

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.